Risperidone in Youth Anorexia: A Promising Solution?

David Rosenberg, a leading expert in child and adolescent psychiatry, discusses his groundbreaking observational study on using risperidone to treat anorexia nervosa in young patients. He highlights the urgent need for effective medications in this challenging area. Despite risperidone being well tolerated, the study reveals it did not significantly improve outcomes like weight gain. Rosenberg emphasizes the complexity of treating this disorder and the necessity for further research into long-term effects and alternative solutions.